Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Apologic Inc
Profile last edited on: 12/14/2006      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1996
First Award
1998
Latest Award
2002
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3130 Highland Avenue Suite 3265
Cincinnati, OH 45219
   (513) 558-3552
   N/A
   N/A
Location: Single
Congr. District: 01
County: Hamilton

Public Profile

ApoLogic, Inc was founded after negotiating a contract and licensing agreement between ApoLogic and the University of Cincinnati where the initial technology was developed in the laboratory of founding scientist. The company focus is drug discovery aimed at apolipoprotein E (apoE) in the area of Alzheimer’s disease and other apoE-related diseases

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$195,086
Phase II Dollars
$749,750
Total Awarded
$944,836

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2002 1 NIH $100,000
Project Title: Novel treatments for Alzheimer's disease
2001 2 NIH $844,836
Project Title: Screening For Novel Alzheimers Disease Drugs

Key People / Management

  Keith Crutcher -- President

  Marcos A Marques

Company News

There are no news available.